
ICON Public Limited Company ICLR
$ 107.7
0.83%
Annual report 2024
added 04-04-2026
ICON Public Limited Company Depreciation & Amortization 2011-2026 | ICLR
Annual Depreciation & Amortization ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 488 M | 586 M | 570 M | 315 M | 66.1 M | 61.6 M | 65.9 M | 61.3 M | 59.6 M | 57.7 M | 52.5 M | 46.5 M | 42.8 M | 38.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 586 M | 38.7 M | 179 M |
Quarterly Depreciation & Amortization ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 141 M | - | 141 M | 17.3 M | 19.8 M | - | 16.8 M | 15.9 M | 16.3 M | - | 15.2 M | 15.2 M | 15.5 M | - | 17.1 M | 17 M | 16.9 M | - | 16.3 M | 14.4 M | 14.4 M | - | 14.5 M | 14.5 M | 15.1 M | - | 14.4 M | 14.2 M | 13.9 M | - | 13.7 M | 12.9 M | 11.5 M | - | 11.6 M | 11.5 M | 11.5 M | - | 10.6 M | 10.8 M | 10.8 M | - | 9.67 M | 9.33 M | 8.97 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 141 M | 8.97 M | 21.5 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
321 M | $ 115.38 | 0.26 % | $ 35.1 B | ||
|
BioNano Genomics
BNGO
|
9.53 M | $ 1.13 | - | $ 6.15 M | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 15.65 | -2.86 % | $ 168 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 16.19 | 0.87 % | $ 863 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.38 | 0.36 % | $ 1.84 M | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 2.3 | - | $ 10.2 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
16 M | $ 23.22 | 0.39 % | $ 645 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 174.38 | -0.74 % | $ 8.64 B | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 498.0 | 0.91 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
750 M | $ 189.16 | -0.22 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
354 M | $ 121.65 | 0.6 % | $ 19.3 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.37 | 0.34 % | $ 405 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 7.79 | 1.3 % | $ 998 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 14.67 | 1.66 % | $ 444 M | ||
|
Guardant Health
GH
|
39.7 M | $ 79.04 | 0.55 % | $ 9.91 B | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
38.3 K | $ 2.73 | 1.49 % | $ 88.6 K | ||
|
Biomerica
BMRA
|
87 K | $ 2.08 | -2.8 % | $ 4.78 M | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 260.87 | -0.02 % | $ 21.7 B | ||
|
Natera
NTRA
|
16.7 M | $ 196.81 | 1.96 % | $ 19.4 B | ||
|
Celcuity
CELC
|
167 K | $ 120.91 | 3.22 % | $ 5.65 B | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 80.04 | -0.68 % | $ 5.4 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 6.54 | -2.1 % | $ 273 M | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 191.24 | -0.15 % | $ 21.2 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.16 | -2.79 % | $ 1.99 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.56 | -0.13 % | $ 2.67 B | ||
|
ENDRA Life Sciences
NDRA
|
44 K | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M |